| rdfs:label | "Levetiracetam Actavis Group"@en |
| schema:description |
"pharmaceutical product"@en
|
|
schema:date |
"2023-11-17T13:43:28+00:00"^^xsd:dateTime |
| schema:version | 2012945764 |
| wikibase:identifiers | 1 |
| wikibase:sitelinks | 0 |
| wikibase:statements | 5 |
| p:P31 | wd:statement/Q29006126-778987E2-7E9B-440D-887B-5A3D35742610 |
| wd:statement/Q29006126-BF08EDAF-DDDA-47A5-A4F5-CC4B1ADC798F | |
| p:P3637 | wd:statement/Q29006126-21E21E9C-29C0-4D68-80B5-A2E6D809314E |
| p:P3781 | wd:statement/Q29006126-1E767DE7-BE41-4160-9839-DC679B36B9F4 |
| p:P4044 | wd:statement/Q29006126-BE67DACC-59C1-4DA8-B04F-5A2263C85074 |
| wdt:P31 | mixture |
| pharmaceutical product | |
| wdt:P3637 | "EMEA/H/C/002305" |
| wdt:P3781 | (S)-etiracetam |
| wdt:P4044 | epilepsy |
Download as: